Back to Search Start Over

EirA Is a Novel Protein Essential for Intracellular Replication of Coxiella burnetii.

Authors :
Kuba M
Neha N
Newton P
Lee YW
Bennett-Wood V
Hachani A
De Souza DP
Nijagal B
Dayalan S
Tull D
McConville MJ
Sansom FM
Newton HJ
Source :
Infection and immunity [Infect Immun] 2020 May 20; Vol. 88 (6). Date of Electronic Publication: 2020 May 20 (Print Publication: 2020).
Publication Year :
2020

Abstract

The zoonotic bacterial pathogen Coxiella burnetii is the causative agent of Q fever, a febrile illness which can cause a serious chronic infection. C. burnetii is a unique intracellular bacterium which replicates within host lysosome-derived vacuoles. The ability of C. burnetii to replicate within this normally hostile compartment is dependent on the activity of the Dot/Icm type 4B secretion system. In a previous study, a transposon mutagenesis screen suggested that the disruption of the gene encoding the novel protein CBU2072 rendered C. burnetii incapable of intracellular replication. This protein, subsequently named EirA ( e ssential for i ntracellular r eplication A), is indispensable for intracellular replication and virulence, as demonstrated by infection of human cell lines and in vivo infection of Galleria mellonella The putative N-terminal signal peptide is essential for protein function but is not required for localization of EirA to the bacterial inner membrane compartment and axenic culture supernatant. In the absence of EirA, C. burnetii remains viable but nonreplicative within the host phagolysosome, as coinfection with C. burnetii expressing native EirA rescues the replicative defect in the mutant strain. In addition, while the bacterial ultrastructure appears to be intact, there is an altered metabolic profile shift in the absence of EirA, suggesting that EirA may impact overall metabolism. Most strikingly, in the absence of EirA, Dot/Icm effector translocation was inhibited even when EirA-deficient C. burnetii replicated in the wild type (WT)-supported Coxiella containing vacuoles. EirA may therefore have a novel role in the control of Dot/Icm activity and represent an important new therapeutic target.<br /> (Copyright © 2020 American Society for Microbiology.)

Details

Language :
English
ISSN :
1098-5522
Volume :
88
Issue :
6
Database :
MEDLINE
Journal :
Infection and immunity
Publication Type :
Academic Journal
Accession number :
32205404
Full Text :
https://doi.org/10.1128/IAI.00913-19